United States · FDA National Drug Code directory

Alexion Pharmaceuticals Inc.

Labeler · 6 source records

The organisation role is retained from the source. Companies with similar names in other sources are not automatically merged.

United States · Source reference 25682-001_acc88f23-0e1f-44f9-be2f-059565a5e25e

SOLIRIS

INJECTION, SOLUTION, CONCENTRATE / Alexion Pharmaceuticals Inc.

United States · Source reference 25682-022_41262953-a849-4095-b9c2-5a1d8b0238cc

Ultomiris

SOLUTION, CONCENTRATE / Alexion Pharmaceuticals Inc.

United States · Source reference 25682-025_41262953-a849-4095-b9c2-5a1d8b0238cc

Ultomiris

SOLUTION, CONCENTRATE / Alexion Pharmaceuticals Inc.

United States · Source reference 25682-028_41262953-a849-4095-b9c2-5a1d8b0238cc

Ultomiris

SOLUTION, CONCENTRATE / Alexion Pharmaceuticals Inc.

United States · Source reference 25682-043_cd0113b0-d5d6-4b03-9f6f-4d80bdcb71fe

Voydeya

TABLET, FILM COATED / Alexion Pharmaceuticals Inc.

United States · Source reference 25682-046_cd0113b0-d5d6-4b03-9f6f-4d80bdcb71fe

Voydeya

KIT / Alexion Pharmaceuticals Inc.

Browse companies in United States →